MeNow Ltd.
Enterprise Software & Infrastructure — Stage: R&D. Est: 2021. Tags: Analysis, Artificial Intelligence, Bioinformatics, Biotechnology, Computational Biology, Generative AI, Healthtech, Life Sciences, Machine Learning, MedTech, Predictive Analytics, SaaS. MeNow is an AI-driven discovery company developing novel natural bioactive compounds for the food, cosmetics, and health sectors. The company combines probabilistic AI, systems biology, and molecular science to identify and validate scalable bioactives with strong efficacy and safety profiles. MeNow has generated proprietary IP in longevity-relevant pathways, including SIRT1 activation, heparanase modulation, and GLP-1–related mechanisms, enabling applications in metabolic health, inflammation, tissue function, and healthspan support.. Web: https://www.menow.ai